COMMUNIQUÉS West-GlobeNewswire

Earth Science Tech, Inc. Annual Shareholder Letter FY Ending 03/31/2025
06/05/2025
Miami, FL, May 06, 2025 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or “Company”), a strategic holding company, focused on value creation through the acquisition, operational optimization, and [...]
Moleculin Announces World Health Organization Approval of “naxtarubicin” as International Non-Proprietary Name for Annamycin
06/05/2025
Annamycin has the potential to be safer and more effective than current prescribed anthracyclines to treat serious, hard-to-treat cancers Ongoing pivotal, adaptive Phase 3 clinical trial (the “MIRACLE” trial) evaluating [...]
Route 92 Medical Announces Settlement of Patent Litigation with Q’Apel Medical
06/05/2025
SAN MATEO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced [...]
Vistin Pharma ASA (VISTN): Mandatory notification of trade and disclosure of large shareholding
06/05/2025
Ferncliff Listed Dai AS has on 6 May 2025 sold 1,234,280 shares in Vistin Pharma ASA at NOK 22.50 per share. Saga Pure ASA has on 6 May 2025 sold 700,000 shares in Vistin Pharma ASA at NOK 22.50 per share. After the [...]
Capricor Therapeutics to Present First Quarter 2025 Financial Results and Recent Corporate Update on May 13
06/05/2025
Company to Host Conference Call, May 13, 2025 at 4:30 p.m. ET SAN DIEGO, May 06, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based [...]
Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis
06/05/2025
The WRAPSODY CIE is designed to help physicians prolong functional vascular access in hemodialysis patients. Approval was supported by superior 12-month target lesion primary patency (70.1%) and access circuit primary [...]
Many Americans Want to Keep Their Natural Teeth—But Aren’t Taking the Right Steps
06/05/2025
CHICAGO, May 06, 2025 (GLOBE NEWSWIRE) -- Americans overwhelmingly want to keep their natural teeth for their lifetime. But a new survey from the American Association of Endodontists reveals a disconnect between that [...]
Empowering Future Health Professionals: 2025 Adam Ferrari Health Science Scholarship Now Accepting Applications
06/05/2025
The Adam Ferrari Health Science Scholarship Awards $20,000 to Students Pursuing Health Science Degrees, Honoring Those Dedicated to Caring for Individuals with Physical Disabilities DENVER, May 06, 2025 (GLOBE NEWSWIRE [...]
Iantrek Hits 2,000 Procedures for New Bio-Interventional Technology - AlloFlo™ Uveo
06/05/2025
CEO Adam Szaronos provides a technology update at the Eyecelerator Conference WHITE PLAINS, N.Y., May 06, 2025 (GLOBE NEWSWIRE) -- Iantrek, Inc., a leader in bio-interventional ophthalmic surgery (BIOS), today announced [...]
TerrAscend Signs Agreement to Acquire Fourth Dispensary in New Jersey
06/05/2025
Union Chill, a single dispensary operator in Hunterdon County, is generating over $11 million in annualized revenue Acquisition further solidifies TerrAscend’s leadership position in the state TORONTO, May 06, 2025 ( [...]
Blue Adderall Pill: Adderall Side Effects in Females & Males - Best Adderall Alternative OTC Supplements - Vyvamind
06/05/2025
Wondering about the blue Adderall pill? Learn about its side effects in females and males, plus the top OTC Adderall alternatives for safe focus and energy. Vyvamind & Nooceptin are best adderall alternative OTC [...]
H.H.C. Group Awarded Multi-State Approvals to Conduct Independent Medical Reviews, Delivering Critical Value to Payors
06/05/2025
ROCKVILLE, Md., May 06, 2025 (GLOBE NEWSWIRE) -- H.H.C. Group (H.H.C.), a leader in reducing healthcare costs by providing high-quality cost containment using claim negotiation, repricing and independent review [...]
Great Speech’s Virtual Speech Therapy Services Now Available to Health Plan Members accessing Claritev’s National PPO Networks
06/05/2025
HOLLYWOOD, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Great Speech , a national leader in virtual speech therapy, is proud to announce a new agreement with Claritev, formerly known as MultiPlan (NYSE:CTEV), a technology and [...]
Alpha Bites Reviews & Complaints Exposed: User Reviews Tested & Verified for Alpha Bites Gummies
06/05/2025
Alpha Bites Gummies in 2025: A Simple Guide to Alpha Bites Review, Complaints, Ingredients, and How They Support Men's Vitality DENVER, May 06, 2025 (GLOBE NEWSWIRE) -- In today’s world, men’s health and energy often [...]
Faithful Fertility Collective Launches 'Miracle in the Making' Program to Support Natural Conception
06/05/2025
Introducing a New Path to Parenthood: "Miracle in the Making" Madison, Wisconsin, May 06, 2025 (GLOBE NEWSWIRE) -- Faithful Fertility Collective , the leader in holistic, faith-centered fertility coaching, is thrilled [...]
Coloplast A/S - Announcement no. 04/2025 - Interim Financial Report, H1 2024/25
06/05/2025
Interim financial results, H1 2024/25 1 October 2024 - 31 March 2025 Coloplast delivered 6% organic growth in Q2, impacted by the product recall in Interventional Urology and a softer quarter in Ostomy Care. Q2 EBIT [...]
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
06/05/2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 6 May 2025 at 18.00 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]
RapidPulse Announces Patient Enrollment Initiated in Pivotal Ischemic Stroke Study
06/05/2025
MIAMI, May 06, 2025 (GLOBE NEWSWIRE) -- RapidPulse, Inc., a Delaware corporation headquartered in Miami, Florida focused on improving the treatment success rate for acute ischemic stroke (AIS), announced patient [...]
Pasithea Therapeutics Announces Pricing of $5 Million Public Offering
06/05/2025
MIAMI, May 06, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics, Corp. (“Pasithea,” or the “Company”) (Nasdaq: KTTA; KTTAW), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK [...]

Pages